ยฉ 2025 grapl ltd.
Regulatory Requirements and Guidance on Advertising and Promotion of Prescription Drugs in the USA
Course Summary
Advertisements and promotional labeling of prescription drugs in the USA must comply with statutory and regulatory requirements. Advertising and promotion are also subject to guidance from the Food and Drug Administration (FDA) and from industry and professional codes of practice. By identifying the requirements and summarizing the extensive guidance that applies, this course and its companions will help you to advertise and promote your products without incurring legal or regulatory sanctions.
In this course we explain how to advertise and promote prescription drugs in various media, whether to healthcare professionals or consumers, in compliance with legal requirements and guidance from the FDA.
In companion courses, we set out the legal framework for regulation, and we deal with considerations that are particular to consumer-directed advertising and online promotion and to interactions with healthcare professionals.
Purchasing Information
When you have completed your course order, Zenosis will finalise the setup of your course materials and contact you on the email address that you provide in your order. You can expect this process to be completed within one business day (using the UK business calendar) of completing your payment.
It is therefore essential that you use your real email address for your order, or indicate in the purchase notes the email address to be used for the course set-up, and check that any messages from Zenosis or grapl are not lost in your junk or spam folder.
You will have access to the course module(s)โfor a period of 180 days after your purchase is complete.
Detailed Course Information
Learning Objectives
โข Identify common issues with drug advertising and promotion
โข Specify regulatory requirements for the presentation of brand and non-proprietary names of drugs
โข Emphasize the importance of consistency with prescribing information, and give examples of types of information that are, and types that are not, consistent
โข Describe how to support claims for products in promotional communications
โข Be truthful and not misleading, reveal material facts, and provide fair balance between effectiveness and risks in promotional communications
โข Avoid the pitfalls of: selective presentation of favorable information, broadening or inadequate representation of indications, use of out-of-date information, misuse of statistics, misleading juxtaposition of information, and misbranding of an investigational drug
โข Deal appropriately with endorsements and testimonials
โข Outline the role of the brief summary and adequate information for use in print advertisements and promotional labeling
โข Outline the role of the major statement, and make adequate provision for access to product labeling, in broadcast advertisements
โข Treat comparative claims with care
โข Make comparative promotional claims regarding price, dosing, and indications
Who will benefit from this course
Sales and marketing personnel need to understand the legal and regulatory requirements that must be met when advertising and promoting prescription drugs in the USA. In addition, this module will be of benefit to regulatory affairs and legal personnel involved with aspects of marketing.
Module Outline
โข Common drug advertising and promotion issues
โข Relate brand and established names
โข Frequency of presentation of established name
โข Be consistent with the prescribing information (PI)
โข Information possibly consistent with the PI
โข Information not consistent with the PI
โข Include only substantiated information
โข Be truthful and not misleading, reveal material facts, and provide fair balance
โข Include information on risks
โข Balance risks and effectiveness
โข Reveal other material information
โข Avoid selective presentation of favorable information
โข Endorsements and testimonials
โข Avoid broadening or inadequate representation of indications
โข Use up-to-date information
โข Use statistics carefully
โข Avoid misleading juxtaposition of information
โข Avoid misbranding of an investigational drug
โข Brief summary and adequate information for use in print media
โข Major statement in broadcast ads
โข Make adequate provision for access to product labeling
โข Treat comparative claims with care
โข Comparisons of price, dosing, and indications
โข FDA examples of violative and non-violative ads
โข Assessment
Roles
Sales and marketing, regulatory affairs, and legal personnel
CPD Points
1.5
Region
Level
Introductory/Intermediate
Course Study Time
Approx 1.5 hours
USA